LNC Therapeutics
Gut microbiota drugs development
LNC Therapeutics has raised €6.5M across 1 funding round from 1 investor, most recently a Series C round in Aug 2017. Based in France; active in Healthtech. Data as of Nov 2026.
Total raised
€6.5M
€6,500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2017-08
latest 2017-08
Funding by year
EUR raised per yearLNC Therapeutics — funding by year — interactive chart.
Data table
| LNC Therapeutics — funding by year | |
|---|---|
| 2017 | €6.5M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-08-25 | Series C | €6.5M | Seventure Partners | View deal → |
Investors
1Related news
Similar companies
same sector, similar size- M2i Life Sciences€6.8MFrance · Healthtech
- Prose€6.9MFrance · Healthtech
- Mauna Kea Technologies€7.0MFrance · Healthtech
- Concilio€6.0MFrance · Healthtech
- Physio-Assist€6.0MFrance · Healthtech
- Medicrea€7.2MFrance · Healthtech
Global coverage: FundingData